Carlos M. Fraga
Cidade Universitaria, RJ 21941902, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Drug Discovery for Histone Deacetylase Inhibition: Past, Present and Future of Zinc-Binding Groups.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 16, 2025
Benign-by-Design SAHA Analogues for Human and Animal Vector-Borne Parasitic Diseases.
Journal: ACS medicinal chemistry letters
Published: May 28, 2024
Selective inhibition of HDAC6 by N-acylhydrazone derivative reduces the proliferation and induces senescence in carcinoma hepatocellular cells.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: May 03, 2024
Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead?
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2024
Molecular hybridization: a powerful tool for multitarget drug discovery.
Journal: Expert opinion on drug discovery
Published: March 08, 2024
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 13, 2024
The Magic Methyl and Its Tricks in Drug Discovery and Development.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 19, 2023
Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry.
Journal: Molecules (Basel, Switzerland)
Published: December 10, 2022
Novel Regioisomeric Analogues of Naphthyl-N-Acylhydrazone Derivatives and Their Anti-Inflammatory Effects.
Journal: International journal of molecular sciences
Published: October 13, 2022
2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 02, 2022
Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 07, 2022
Last Updated: 09/26/2026